Esketamine for postoperative quality of recovery in mastectomy :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Effect of various Esketamine doses on quality of recovery and pain after mastectomy

Breast Pain Breast Pain
Breast Pain Breast Pain

The purpose of a randomized, double-blind, controlled study was to determine the influence of various Esketamine doses on postoperative quality of recovery in females undergoing modified radical mastectomy.

See All

Key take away

Different doses of Esketamine infusions (particularly 4 µg/kg/h) improved the quality of recovery 1 and 3 days after modified radical mastectomy and also decreased the intensity of postoperative pain.

Background

The purpose of a randomized, double-blind, controlled study was to determine the influence of various Esketamine doses on postoperative quality of recovery in females undergoing modified radical mastectomy.

Method

Overall, 99 female subjects were randomly divided into the control group (Group C: Received normal saline), the high-dose Esketamine group (Group E2: 0.5 mg/kg loading, 4 µg/kg/h infusion), and the low-dose Esketamine group (Group E1: 0.5 mg/kg loading, 2 µg/kg/h infusion). The quality of recovery-15 (QoR-15) ratings on postoperative day 1 (POD1) and day 3 (POD3) were the major endpoints ascertained.

The secondary outcomes were the POD1 sleep quality scores, the bispectral index values at 10, 30, and 60 minutes following surgery, the numeric rating scale (NRS) pain scores within 24 h post vomiting, sleepiness, surgery, intraoperative awareness, nausea, and nightmare.

Result

On POD1 and POD3, group E1 and group E2 had higher total QoR-15 scores than group C. At 10, 30, and 60 minutes following surgery, group E1 and group E2 had greater POD1 and bispectral index scores for sleep quality than group C. The NRS pain scores in groups E1 and E2 at 2, 4, 6, 12 and 24 h after surgery were less than those in group C. In comparison to group E1, group E2 had reduced NRS pain scores at 6, 12, and 24 hours following surgery. In comparison to group C, group E1 and group E2 experienced more instances of sleepiness.

Conclusion

The various Esketamine infusion doses, specifically 4 µg/kg/h mitigated postoperative pain and also helped patients having modified radical mastectomy recover more quickly after surgery. However, Esketamine use raised the occurrence of drowsiness and bispectral index values.

Source:

Drug Design, Development and Therapy

Article:

Effects of the Different Doses of Esketamine on Postoperative Quality of Recovery in Patients Undergoing Modified Radical Mastectomy: A Randomized, Double-Blind, Controlled Trial

Authors:

Min Zhu et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: